Raymond J. Henley Iii

Array ( [id] => 7367002 [patent_doc_number] => 20040005995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method for reducing exacerbations associated with copd' [patent_app_type] => new [patent_app_number] => 10/343078 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3338 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005995.pdf [firstpage_image] =>[orig_patent_app_number] => 10343078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865653 [patent_doc_number] => 20030191179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Methods for administration of paclitaxel' [patent_app_type] => new [patent_app_number] => 10/351262 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16150 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191179.pdf [firstpage_image] =>[orig_patent_app_number] => 10351262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706858 [patent_doc_number] => 20030153592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Method' [patent_app_type] => new [patent_app_number] => 10/349431 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2385 [patent_no_of_claims] => 128 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153592.pdf [firstpage_image] =>[orig_patent_app_number] => 10349431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311953 [patent_doc_number] => 06613785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Use of glucose uptake enhancer for reducing post-ischemic injury of the heart' [patent_app_type] => B2 [patent_app_number] => 10/348456 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4740 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613785.pdf [firstpage_image] =>[orig_patent_app_number] => 10348456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1222553 [patent_doc_number] => RE038443 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-02-24 [patent_title] => 'Stabilized aspirin compositions and method of preparation of oral and topical use' [patent_app_type] => E1 [patent_app_number] => 10/346064 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2333 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038443.pdf [firstpage_image] =>[orig_patent_app_number] => 10346064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631278 [patent_doc_number] => 06635654 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Ophthalmic compositions containing loratadine' [patent_app_type] => B1 [patent_app_number] => 10/340355 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2148 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635654.pdf [firstpage_image] =>[orig_patent_app_number] => 10340355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368568 [patent_doc_number] => 20040006138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Pharmaceutical composition useful for treating chronic myeloid leukemia' [patent_app_type] => new [patent_app_number] => 10/338689 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4343 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006138.pdf [firstpage_image] =>[orig_patent_app_number] => 10338689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228493 [patent_doc_number] => 06696419 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-24 [patent_title] => 'Boron compounds and complexes as anti-inflammatory agents' [patent_app_type] => B1 [patent_app_number] => 10/129938 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3562 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696419.pdf [firstpage_image] =>[orig_patent_app_number] => 10129938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730859 [patent_doc_number] => 20030187049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Compositions based on aminoacids, suitable for improving muscle performance' [patent_app_type] => new [patent_app_number] => 10/332237 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3586 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187049.pdf [firstpage_image] =>[orig_patent_app_number] => 10332237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139565 [patent_doc_number] => 06776979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-17 [patent_title] => 'Periodontal treatment compound and method of use' [patent_app_type] => B2 [patent_app_number] => 10/334373 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6379 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/776/06776979.pdf [firstpage_image] =>[orig_patent_app_number] => 10334373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474518 [patent_doc_number] => 20040122067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Treatment of chronic heart failure' [patent_app_type] => new [patent_app_number] => 10/325420 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4628 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122067.pdf [firstpage_image] =>[orig_patent_app_number] => 10325420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6652053 [patent_doc_number] => 20030105138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method of treatment for decreasing mortality resulting from congestive heart failure' [patent_app_type] => new [patent_app_number] => 10/324856 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3739 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105138.pdf [firstpage_image] =>[orig_patent_app_number] => 10324856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651867 [patent_doc_number] => 20030105108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies' [patent_app_type] => new [patent_app_number] => 10/311907 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3432 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105108.pdf [firstpage_image] =>[orig_patent_app_number] => 10311907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959743 [patent_doc_number] => 20050215624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'REGULATION OF NAD(P)H OXIDASE GROWTH AND TRANSCRIPTION IN MELANOMA CELLS' [patent_app_type] => utility [patent_app_number] => 10/493936 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9316 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215624.pdf [firstpage_image] =>[orig_patent_app_number] => 10493936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105531 [patent_doc_number] => 20050107450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Dosing regimen for ppar-gamma activators' [patent_app_type] => utility [patent_app_number] => 10/499248 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3064 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107450.pdf [firstpage_image] =>[orig_patent_app_number] => 10499248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760705 [patent_doc_number] => 20030124066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Stable oral compositions comprising casein phosphopeptide complexes and fluoride' [patent_app_type] => new [patent_app_number] => 10/320871 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9025 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124066.pdf [firstpage_image] =>[orig_patent_app_number] => 10320871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761944 [patent_doc_number] => 20030125306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Histone deacetylase inhibitors' [patent_app_type] => new [patent_app_number] => 10/318225 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15269 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125306.pdf [firstpage_image] =>[orig_patent_app_number] => 10318225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 583354 [patent_doc_number] => 07449492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Therapeutic agents—I' [patent_app_type] => utility [patent_app_number] => 10/315288 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 24390 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449492.pdf [firstpage_image] =>[orig_patent_app_number] => 10315288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253566 [patent_doc_number] => 06670355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Method of treating cardiovascular disease' [patent_app_type] => B2 [patent_app_number] => 10/313217 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4270 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670355.pdf [firstpage_image] =>[orig_patent_app_number] => 10313217 [rel_patent_id] =>[rel_patent_doc_number] =>)